Nathalie Auber
@Sofinnova Investments, Inc.
Latest period2024 - Q3ReportedManaged Assets$1.26BTotal holdings58
Assets growth rate-34.51%Assets growth rate (2-Q avg)-13.66%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 58 positions.
Assets under management
The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.26B in assets, with a quarterly growth rate of -34.51% and a 2-quarter average growth rate of -13.66%. The portfolio is managed by Nathalie Auber, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
KURAKura Oncology Inc
| 0.47% | $5.801M 296,884 shares@ $19.54 avg price | Decreased -64.02% |
IMTXImmatics N.v
| 0.35% | $4.405M 386,100 shares@ $11.41 avg price | Decreased -51.53% |
NARIInari Med Inc
| 0.3% | $3.725M 90,327 shares@ $41.24 avg price | Decreased -42.03% |
EXASExact Sciences Corp
| 0.21% | $2.564M 37,637 shares@ $68.12 avg price | Decreased -79.3% |
CATXPerspective Therapeutics Inc
| 0.13% | $1.61M 120,632 shares@ $13.35 avg price | Decreased -8.67% |